Companion Diagnostics Market

Question ^*

Which stage of CDx development do you find most challenging?

1. Target identification & validation

2. Assay development & optimization

3. Clinical trial design & execution

4. Regulatory approval

5. Market access & reimbursement

Save & Next

Question ^*

What is your biggest concern regarding CDx utilization in clinical practice?

1. Cost and affordability

2. Turnaround time for results

3. Accuracy and reliability of results

4. Accessibility of testing facilities

5. Interpretation and application of results

Save & Next

Question ^*

What type of CDx information/support would be most valuable to you?

1. Evidence-based guidelines for test selection

2. Educational materials on CDx interpretation

3. Decision support tools for treatment planning

4. Assistance with reimbursement applications

5. Real-world data on CDx performance

Save & Next

Question ^*

What features are most important in a CDx solution?

1. High sensitivity and specificity

2. Fast turnaround time

3. Ease of use/implementation

4. Comprehensive biomarker coverage

5. Cost-effectiveness

Save & Next

Question ^*

What prevents you from utilizing CDx more often?

1. Lack of awareness/understanding

2. Limited access to appropriate testing

3. Concerns about reimbursement

4. Insufficient evidence to support use

5. Other (Please specify)

Save & Next